Current location - Training Enrollment Network - Books and materials - Experience of China Pharmacopoeia
Experience of China Pharmacopoeia
The 20 10 edition of China Pharmacopoeia is published in three parts, one is Chinese medicine, the other is chemical medicine, and the third is biological products. China Pharmacopoeia (version 20 10) contains more than 4,600 varieties, including new varieties 1300, which basically covers the national essential drugs list and the national medical insurance list.

The promulgation and implementation of the 20 10 edition of China Pharmacopoeia will certainly play an active and important role in the process of comprehensively improving the quality of drugs in China, and will further expand and enhance the positive influence of China's Pharmacopoeia in the world.

Through rotation training, I also learned the drafting principles, main supplementary and revised contents and technical points of China Pharmacopoeia 20 10, which has important guiding significance for the accurate implementation of China Pharmacopoeia 20 10.

People's Republic of China (PRC) Pharmacopoeia (China Pharmacopoeia for short) was published by China Medical Science and Technology Press on June 5, 20/KLOC-0, and was created by the State Pharmacopoeia Committee.

China Pharmacopoeia is published in four parts: one part contains medicinal materials and decoction pieces, vegetable oil and extracts, prescription preparations and single-flavor preparations; The second part includes chemicals, antibiotics, biochemical drugs and radioactive drugs; Three collections of biological products; Four general principles of collection and loading, including: general principles of preparations, inspection methods, guiding principles, general principles related to reference substances and test solutions, pharmaceutical excipients, etc.

On July 2, 2020, the State Administration of Pharmaceutical Products and the National Health and Wellness Commission issued an announcement, officially publishing the 2020 edition of People's Republic of China (PRC) Pharmacopoeia. The new edition of China Pharmacopoeia was officially implemented on February 30th, 2020. The new edition of China Pharmacopoeia added 3 19 species, revised 3 177 species, no longer included 10 species, and adjusted and merged 4 species to include 591/kloc-0 species.

Experience refers to a sensitive text written after reading and practicing. Chinese reading experience is similar to math reading notes; Experience refers to applying what you have learned to practice, reflecting on the learning content through practice, and recording the words, which is similar to summing up experience.